Literature DB >> 18855023

Analysis of CYP7B1 in non-consanguineous cases of hereditary spastic paraplegia.

Rebecca Schüle1, Elisabeth Brandt, Kathrin N Karle, Maria Tsaousidou, Stephan Klebe, Sven Klimpe, Michaela Auer-Grumbach, Andrew H Crosby, Christian A Hübner, Ludger Schöls, Thomas Deufel, Christian Beetz.   

Abstract

Hereditary spastic paraplegia (HSP) is a neurodegenerative condition defined clinically by lower limb spasticity and weakness. Homozygous mutations in CYP7B1 have been identified in several consanguineous families that represented HSP type 5 (SPG5), one of the many genetic forms of the disease. We used direct sequencing and multiplex ligation-dependent probe amplification to screen for CYP7B1 alterations in apparently sporadic HSP patients (n = 12) as well as index patients from non-consanguineous families with recessive (n = 8) and dominant (n = 8) transmission of HSP. One sporadic patient showing HSP as well as optic atrophy carried a homozygous nonsense mutation. Compound heterozygosity was observed in a recessive family with a clinically pure phenotype. A heterozygous missense change segregated in a small dominant family. We also found a significant association of a known coding polymorphism with cerebellar signs complicating a primary HSP phenotype. Our findings suggest CYP7B1 alterations to represent a rather frequent cause of HSP that should be considered in patients with various clinical presentations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18855023     DOI: 10.1007/s10048-008-0158-9

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  22 in total

1.  The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity.

Authors:  R Schüle; T Holland-Letz; S Klimpe; J Kassubek; T Klopstock; V Mall; S Otto; B Winner; L Schöls
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

2.  High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia.

Authors:  C Beetz; A O H Nygren; J Schickel; M Auer-Grumbach; K Bürk; G Heide; J Kassubek; S Klimpe; T Klopstock; F Kreuz; S Otto; R Schüle; L Schöls; A-D Sperfeld; O W Witte; T Deufel
Journal:  Neurology       Date:  2006-10-11       Impact factor: 9.910

3.  Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia.

Authors:  Christel Depienne; Estelle Fedirko; Sylvie Forlani; Cécile Cazeneuve; Pascale Ribaï; Imed Feki; Chantal Tallaksen; Karine Nguyen; Bruno Stankoff; Merle Ruberg; Giovanni Stevanin; Alexandra Durr; Alexis Brice
Journal:  J Med Genet       Date:  2006-11-10       Impact factor: 6.318

4.  Screening of hereditary spastic paraplegia patients for alterations at NIPA1 mutational hotspots.

Authors:  Christian Beetz; Rebecca Schüle; Stephan Klebe; Sven Klimpe; Thomas Klopstock; Arnaud Lacour; Susanne Otto; Anne-Dorte Sperfeld; Bart van de Warrenburg; Ludger Schöls; Thomas Deufel
Journal:  J Neurol Sci       Date:  2008-01-14       Impact factor: 3.181

5.  Linkage of 'pure' autosomal recessive familial spastic paraplegia to chromosome 8 markers and evidence of genetic locus heterogeneity.

Authors:  A Hentati; M A Pericak-Vance; W Y Hung; S Belal; N Laing; R M Boustany; F Hentati; M Ben Hamida; T Siddique
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

6.  Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome.

Authors:  Sylvain Hanein; Elodie Martin; Amir Boukhris; Paula Byrne; Cyril Goizet; Abdelmadjid Hamri; Ali Benomar; Alexander Lossos; Paola Denora; José Fernandez; Nizar Elleuch; Sylvie Forlani; Alexandra Durr; Imed Feki; Michael Hutchinson; Filippo M Santorelli; Chokri Mhiri; Alexis Brice; Giovanni Stevanin
Journal:  Am J Hum Genet       Date:  2008-04       Impact factor: 11.025

7.  REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31.

Authors:  Christian Beetz; Rebecca Schüle; Tine Deconinck; Khanh-Nhat Tran-Viet; Hui Zhu; Berry P H Kremer; Suzanna G M Frints; Wendy A G van Zelst-Stams; Paula Byrne; Susanne Otto; Anders O H Nygren; Jonathan Baets; Katrien Smets; Berten Ceulemans; Bernard Dan; Narasimhan Nagan; Jan Kassubek; Sven Klimpe; Thomas Klopstock; Henning Stolze; Hubert J M Smeets; Constance T R M Schrander-Stumpel; Michael Hutchinson; Bart P van de Warrenburg; Corey Braastad; Thomas Deufel; Margaret Pericak-Vance; Ludger Schöls; Peter de Jonghe; Stephan Züchner
Journal:  Brain       Date:  2008-03-05       Impact factor: 13.501

8.  Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration.

Authors:  Maria K Tsaousidou; Karim Ouahchi; Tom T Warner; Yi Yang; Michael A Simpson; Nigel G Laing; Philip A Wilkinson; Ricardo E Madrid; Heema Patel; Faycal Hentati; Michael A Patton; Afif Hentati; Philippa J Lamont; Teepu Siddique; Andrew H Crosby
Journal:  Am J Hum Genet       Date:  2008-01-18       Impact factor: 11.025

9.  A novel locus for autosomal dominant "uncomplicated" hereditary spastic paraplegia maps to chromosome 8p21.1-q13.3.

Authors:  Sylvain Hanein; Alexandra Dürr; Pascale Ribai; Sylvie Forlani; Anne-Louise Leutenegger; Isabelle Nelson; Marie-Claude Babron; Nizar Elleuch; Christel Depienne; Céline Charon; Alexis Brice; Giovanni Stevanin
Journal:  Hum Genet       Date:  2007-06-28       Impact factor: 4.132

10.  Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease.

Authors:  G Casari; M De Fusco; S Ciarmatori; M Zeviani; M Mora; P Fernandez; G De Michele; A Filla; S Cocozza; R Marconi; A Dürr; B Fontaine; A Ballabio
Journal:  Cell       Date:  1998-06-12       Impact factor: 41.582

View more
  15 in total

1.  The interaction between metabolism, cancer and cardiovascular disease, connected by 27-hydroxycholesterol.

Authors:  Wan-Ru Lee; Tomonori Ishikawa; Michihisa Umetani
Journal:  Clin Lipidol       Date:  2014

2.  Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.

Authors:  Ludger Schöls; Tim W Rattay; Peter Martus; Christoph Meisner; Jonathan Baets; Imma Fischer; Christine Jägle; Matthew J Fraidakis; Andrea Martinuzzi; Jonas Alex Saute; Marina Scarlato; Antonella Antenora; Claudia Stendel; Philip Höflinger; Charles Marques Lourenco; Lisa Abreu; Katrien Smets; Martin Paucar; Tine Deconinck; Dana M Bis; Sarah Wiethoff; Peter Bauer; Alessia Arnoldi; Wilson Marques; Laura Bannach Jardim; Stefan Hauser; Chiara Criscuolo; Alessandro Filla; Stephan Züchner; Maria Teresa Bassi; Thomas Klopstock; Peter De Jonghe; Ingemar Björkhem; Rebecca Schüle
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

Review 3.  Disorders of bile acid synthesis.

Authors:  Peter Theodore Clayton
Journal:  J Inherit Metab Dis       Date:  2011-01-13       Impact factor: 4.982

4.  Side chain-oxidized oxysterols regulate the brain renin-angiotensin system through a liver X receptor-dependent mechanism.

Authors:  Laura Mateos; Muhammad-Al-Mustafa Ismail; Francisco-Javier Gil-Bea; Rebecca Schüle; Ludger Schöls; Maura Heverin; Ronnie Folkesson; Ingemar Björkhem; Angel Cedazo-Mínguez
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

5.  A total of 220 patients with autosomal dominant spastic paraplegia do not display mutations in the SLC33A1 gene (SPG42).

Authors:  Nina A Schlipf; Christian Beetz; Rebecca Schüle; Giovanni Stevanin; Anne Kjersti Erichsen; Sylvie Forlani; Cécile Zaros; Kathrin Karle; Stephan Klebe; Sven Klimpe; Alexandra Durr; Susanne Otto; Chantal M E Tallaksen; Olaf Riess; Alexis Brice; Peter Bauer; Ludger Schöls
Journal:  Eur J Hum Genet       Date:  2010-05-12       Impact factor: 4.246

6.  Genetic connections between neurological disorders and cholesterol metabolism.

Authors:  Ingemar Björkhem; Valerio Leoni; Steve Meaney
Journal:  J Lipid Res       Date:  2010-05-13       Impact factor: 5.922

7.  Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis.

Authors:  Rebecca Schüle; Teepu Siddique; Han-Xiang Deng; Yi Yang; Sandra Donkervoort; Magnus Hansson; Ricardo E Madrid; Nailah Siddique; Ludger Schöls; Ingemar Björkhem
Journal:  J Lipid Res       Date:  2009-10-07       Impact factor: 5.922

Review 8.  CYP7B1: one cytochrome P450, two human genetic diseases, and multiple physiological functions.

Authors:  Ashlee R Stiles; Jeffrey G McDonald; David R Bauman; David W Russell
Journal:  J Biol Chem       Date:  2009-08-16       Impact factor: 5.157

Review 9.  Re-adopting classical nuclear receptors by cholesterol metabolites.

Authors:  Michihisa Umetani
Journal:  J Steroid Biochem Mol Biol       Date:  2015-11-10       Impact factor: 4.292

Review 10.  Cytochromes p450: roles in diseases.

Authors:  Irina A Pikuleva; Michael R Waterman
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.